CLSI MM07-A2 (R2018) – Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline–Second Edition, MM07A2E
This document addresses fluorescence in situ hybridization methods for medical genetic determinations, identification of chromosomal abnormalities, and gene amplification. Recommendations for probe and assay development, manufacture, qualification, verification, and validation; instrument requirements; quality assurance; and evaluation of results are also included.
